skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 160  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding
Material Type:
Article
Add to My Research

Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding

Cell, 2020-09, Vol.182 (5), p.1295-1310.e20 [Peer Reviewed Journal]

2020 The Author(s) ;Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;Distributed under a Creative Commons Attribution 4.0 International License ;2020 The Author(s) 2020 ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2020.08.012 ;PMID: 32841599

Digital Resources/Online E-Resources

2
Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19
Material Type:
Article
Add to My Research

Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19

Cell, 2021-01, Vol.184 (1), p.169-183.e17 [Peer Reviewed Journal]

2020 Elsevier Inc. ;Copyright © 2020 Elsevier Inc. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020 Elsevier Inc. 2020 Elsevier Inc. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2020.11.029 ;PMID: 33296701

Digital Resources/Online E-Resources

3
Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Material Type:
Article
Add to My Research

Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection

The Journal of infectious diseases, 2021-02, Vol.223 (2), p.197-205 [Peer Reviewed Journal]

The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. 2020 ;The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. ;ISSN: 0022-1899 ;EISSN: 1537-6613 ;DOI: 10.1093/infdis/jiaa618 ;PMID: 33535236

Full text available

4
Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays
Material Type:
Article
Add to My Research

Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays

Viruses, 2020-05, Vol.12 (5), p.513 [Peer Reviewed Journal]

COPYRIGHT 2020 MDPI AG ;Attribution ;2020 by the authors. 2020 ;ISSN: 1999-4915 ;EISSN: 1999-4915 ;DOI: 10.3390/v12050513 ;PMID: 32384820

Full text available

5
Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial Virus
Material Type:
Article
Add to My Research

Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial Virus

Cell, 2019-03, Vol.176 (6), p.1420-1431.e17 [Peer Reviewed Journal]

2019 The Author(s) ;Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved. ;2019 The Author(s) 2019 ;ISSN: 0092-8674 ;ISSN: 1097-4172 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2019.01.046 ;PMID: 30849373

Full text available

6
Designed proteins induce the formation of nanocage-containing extracellular vesicles
Material Type:
Article
Add to My Research

Designed proteins induce the formation of nanocage-containing extracellular vesicles

Nature (London), 2016-12, Vol.540 (7632), p.292-295 [Peer Reviewed Journal]

COPYRIGHT 2016 Nature Publishing Group ;COPYRIGHT 2016 Nature Publishing Group ;Copyright Nature Publishing Group Dec 8, 2016 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature20607 ;PMID: 27919066 ;CODEN: NATUAS

Full text available

7
Complete and cooperative in vitro assembly of computationally designed self-assembling protein nanomaterials
Material Type:
Article
Add to My Research

Complete and cooperative in vitro assembly of computationally designed self-assembling protein nanomaterials

Nature communications, 2021-02, Vol.12 (1), p.883-14, Article 883 [Peer Reviewed Journal]

The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-021-21251-y ;PMID: 33563988

Full text available

8
Enhancing and shaping the immunogenicity of native-like HIV-1 envelope trimers with a two-component protein nanoparticle
Material Type:
Article
Add to My Research

Enhancing and shaping the immunogenicity of native-like HIV-1 envelope trimers with a two-component protein nanoparticle

Nature communications, 2019-09, Vol.10 (1), p.4272-17, Article 4272 [Peer Reviewed Journal]

2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2019 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-019-12080-1 ;PMID: 31537780

Full text available

9
Tailored design of protein nanoparticle scaffolds for multivalent presentation of viral glycoprotein antigens
Material Type:
Article
Add to My Research

Tailored design of protein nanoparticle scaffolds for multivalent presentation of viral glycoprotein antigens

eLife, 2020-08, Vol.9 [Peer Reviewed Journal]

2020. This work is published under http://creativecommons.org/publicdomain/zero/1.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2050-084X ;EISSN: 2050-084X ;DOI: 10.7554/ELIFE.57659 ;PMID: 32748788

Full text available

10
Serological identification of SARS-CoV-2 infections among children visiting a hospital during the initial Seattle outbreak
Material Type:
Article
Add to My Research

Serological identification of SARS-CoV-2 infections among children visiting a hospital during the initial Seattle outbreak

Nature communications, 2020-09, Vol.11 (1), p.4378-4378, Article 4378 [Peer Reviewed Journal]

The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-020-18178-1 ;PMID: 32873791

Full text available

11
Structural and functional evaluation of de novo-designed, two-component nanoparticle carriers for HIV Env trimer immunogens
Material Type:
Article
Add to My Research

Structural and functional evaluation of de novo-designed, two-component nanoparticle carriers for HIV Env trimer immunogens

PLoS pathogens, 2020-08, Vol.16 (8), p.e1008665 [Peer Reviewed Journal]

COPYRIGHT 2020 Public Library of Science ;COPYRIGHT 2020 Public Library of Science ;2020 Antanasijevic et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Antanasijevic et al 2020 Antanasijevic et al ;ISSN: 1553-7374 ;ISSN: 1553-7366 ;EISSN: 1553-7374 ;DOI: 10.1371/JOURNAL.PPAT.1008665 ;PMID: 32780770

Full text available

12
Induction of cross-neutralizing antibodies by a permuted hepatitis C virus glycoprotein nanoparticle vaccine candidate
Material Type:
Article
Add to My Research

Induction of cross-neutralizing antibodies by a permuted hepatitis C virus glycoprotein nanoparticle vaccine candidate

Nature communications, 2022-11, Vol.13 (1), p.7271-16, Article 7271 [Peer Reviewed Journal]

2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-022-34961-8 ;PMID: 36434005

Full text available

13
Structure-based design of stabilized recombinant influenza neuraminidase tetramers
Material Type:
Article
Add to My Research

Structure-based design of stabilized recombinant influenza neuraminidase tetramers

Nature communications, 2022-04, Vol.13 (1), p.1825-1825, Article 1825 [Peer Reviewed Journal]

2022. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply. ;This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2022 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-022-29416-z ;PMID: 35383176

Full text available

14
Polyclonal antibody responses to HIV Env immunogens resolved using cryoEM
Material Type:
Article
Add to My Research

Polyclonal antibody responses to HIV Env immunogens resolved using cryoEM

Nature communications, 2021-08, Vol.12 (1), p.4817-4817, Article 4817 [Peer Reviewed Journal]

2021. The Author(s). ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-021-25087-4 ;PMID: 34376662

Full text available

15
Nanoparticle display of prefusion coronavirus spike elicits S1-focused cross-reactive antibody response against diverse coronavirus subgenera
Material Type:
Article
Add to My Research

Nanoparticle display of prefusion coronavirus spike elicits S1-focused cross-reactive antibody response against diverse coronavirus subgenera

Nature communications, 2023-10, Vol.14 (1), p.6195-6195, Article 6195 [Peer Reviewed Journal]

2023. Springer Nature Limited. ;The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Springer Nature Limited 2023 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-023-41661-4 ;PMID: 37794071

Full text available

16
Structure and folding of a designed knotted protein
Material Type:
Article
Add to My Research

Structure and folding of a designed knotted protein

Proceedings of the National Academy of Sciences - PNAS, 2010-11, Vol.107 (48), p.20732-20737 [Peer Reviewed Journal]

Copyright National Academy of Sciences Nov 30, 2010 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.1007602107 ;PMID: 21068371

Full text available

17
Fast and versatile sequence-independent protein docking for nanomaterials design using RPXDock
Material Type:
Article
Add to My Research

Fast and versatile sequence-independent protein docking for nanomaterials design using RPXDock

PLoS computational biology, 2023-05, Vol.19 (5), p.e1010680-e1010680 [Peer Reviewed Journal]

Copyright: © 2023 Sheffler et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ;COPYRIGHT 2023 Public Library of Science ;2023 Sheffler et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 Sheffler et al 2023 Sheffler et al ;ISSN: 1553-7358 ;ISSN: 1553-734X ;EISSN: 1553-7358 ;DOI: 10.1371/journal.pcbi.1010680 ;PMID: 37216343

Full text available

18
Combinatorial immune refocusing within the influenza hemagglutinin RBD improves cross-neutralizing antibody responses
Material Type:
Article
Add to My Research

Combinatorial immune refocusing within the influenza hemagglutinin RBD improves cross-neutralizing antibody responses

Cell reports (Cambridge), 2023-12, Vol.42 (12), p.113553-113553, Article 113553 [Peer Reviewed Journal]

2023 The Authors ;Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved. ;ISSN: 2211-1247 ;EISSN: 2211-1247 ;DOI: 10.1016/j.celrep.2023.113553 ;PMID: 38096052

Full text available

19
Antigen spacing on protein nanoparticles influences antibody responses to vaccination
Material Type:
Article
Add to My Research

Antigen spacing on protein nanoparticles influences antibody responses to vaccination

Cell reports (Cambridge), 2023-12, Vol.42 (12), p.113552-113552, Article 113552 [Peer Reviewed Journal]

2023 The Authors ;Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved. ;ISSN: 2211-1247 ;EISSN: 2211-1247 ;DOI: 10.1016/j.celrep.2023.113552 ;PMID: 38096058

Full text available

20
Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: A randomised, placebo-controlled, observer-blinded phase 1/2 trial
Material Type:
Article
Add to My Research

Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: A randomised, placebo-controlled, observer-blinded phase 1/2 trial

EClinicalMedicine, 2022-09, Vol.51, p.101569-101569, Article 101569 [Peer Reviewed Journal]

2022 The Authors ;2022 Published by Elsevier Ltd. 2022 ;ISSN: 2589-5370 ;EISSN: 2589-5370 ;DOI: 10.1016/j.eclinm.2022.101569 ;PMID: 35879941

Full text available

Results 1 - 20 of 160  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (77)

Refine My Results

Creation Date 

From To
  1. Before 2011  (2)
  2. 2011 To 2014  (5)
  3. 2015 To 2016  (8)
  4. 2017 To 2019  (17)
  5. After 2019  (129)
  6. More options open sub menu

Resource Type 

  1. Articles  (91)
  2. Patents  (69)
  3. More options open sub menu

Language 

  1. English  (147)
  2. French  (12)
  3. Japanese  (10)
  4. German  (8)
  5. Spanish  (8)
  6. Chinese  (5)
  7. Korean  (5)
  8. Portuguese  (3)
  9. More options open sub menu

Searching Remote Databases, Please Wait